🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Lithium Versus Lamotrigine in Bipolar Disorder, Type II

RecruitingPhase 4Ages 18 Years - 70 YearsAllUniversity Hospital Bispebjerg and Frederiksberg
NCT06184581 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Bipolar disorder, type II with diagnosis confirmed by SCAN interview * Age 18-70 years * Habile (i.e., able to give informed consent) Exclusion Criteria: * Past non-response or intolerance to lamotrigine or lithium with \> 6 weeks treatment at an adequate dosage * Currently taking mood stabilizers at enrollment in CADIC * Severe chronic kidney disease * Severe cardiac insufficiency * Brugadas syndrome * Severe hypothyroidism despite treatment * Women who are pregnant, breastfeeding or planning pregnancy in near future.
💊

What it tests

  • Lithium Carbonate
  • Lamotrigine
📍

Where

1 site
Psychiatric Center Copenhagen
Copenhagen, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy